Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate

Cell Rep. 2024 Oct 22;43(10):114807. doi: 10.1016/j.celrep.2024.114807. Epub 2024 Oct 3.

Abstract

Stemness and pluripotency are mediated by transcriptional master regulators that promote self-renewal and repress cell differentiation, among which is the high-mobility group (HMG) box transcription factor SOX2. Dysregulated SOX2 expression, by contrast, leads to transcriptional aberrations relevant to oncogenic transformation, cancer progression, metastasis, therapy resistance, and relapse. Here, we report a post-transcriptional mechanism by which the cytosolic pool of SOX2 contributes to these events in an unsuspected manner. Specifically, a low-complexity region within SOX2's C-terminal segment connects to the ribosome to modulate the expression of cognate downstream factors. Independent of nuclear structures or DNA, this C-terminal functionality alone changes metabolic properties and induces non-adhesive growth when expressed in the cytosol of SOX2 knockout cells. We thus propose a revised model of SOX2 action where nuclear and cytosolic fractions cooperate to impose cell fate decisions via both transcriptional and translational mechanisms.

Keywords: CP: Developmental biology; CP: Molecular biology; SOX2; cancer; differentiation; ribosome; stem cell; translation.

MeSH terms

  • Animals
  • Cell Differentiation
  • Cell Nucleus* / metabolism
  • Cytosol* / metabolism
  • Humans
  • Mice
  • Protein Biosynthesis
  • SOXB1 Transcription Factors* / genetics
  • SOXB1 Transcription Factors* / metabolism
  • Transcription, Genetic*

Substances

  • SOXB1 Transcription Factors
  • SOX2 protein, human